ZA201602703B - A molecular marker of plasmodium falciparum artemisinin resistance - Google Patents

A molecular marker of plasmodium falciparum artemisinin resistance

Info

Publication number
ZA201602703B
ZA201602703B ZA2016/02703A ZA201602703A ZA201602703B ZA 201602703 B ZA201602703 B ZA 201602703B ZA 2016/02703 A ZA2016/02703 A ZA 2016/02703A ZA 201602703 A ZA201602703 A ZA 201602703A ZA 201602703 B ZA201602703 B ZA 201602703B
Authority
ZA
South Africa
Prior art keywords
molecular marker
plasmodium falciparum
artemisinin resistance
artemisinin
resistance
Prior art date
Application number
ZA2016/02703A
Inventor
Frederic Ariey
Odile Puijalon
Didier Menard
Francoise Benoit-Vical
Johann Beghain
Benoit Witkowski
Jean-Christophe Barale
Christiane Bouchier
Nimol Khim
Original Assignee
Pasteur Institut
Inst Pasteur Du Cambodge
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Pasteur Du Cambodge, Centre Nat Rech Scient filed Critical Pasteur Institut
Publication of ZA201602703B publication Critical patent/ZA201602703B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445Plasmodium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2016/02703A 2013-11-15 2016-04-19 A molecular marker of plasmodium falciparum artemisinin resistance ZA201602703B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361904651P 2013-11-15 2013-11-15
US201462062439P 2014-10-10 2014-10-10
PCT/IB2014/002910 WO2015071759A1 (en) 2013-11-15 2014-11-14 A molecular marker of plasmodium falciparum artemisinin resistance

Publications (1)

Publication Number Publication Date
ZA201602703B true ZA201602703B (en) 2019-12-18

Family

ID=52440720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2016/02703A ZA201602703B (en) 2013-11-15 2016-04-19 A molecular marker of plasmodium falciparum artemisinin resistance

Country Status (12)

Country Link
US (2) US10900093B2 (en)
EP (1) EP3068903B1 (en)
JP (2) JP6667445B2 (en)
KR (1) KR102283408B1 (en)
CN (1) CN105940115B (en)
AU (1) AU2014349828B2 (en)
BR (1) BR112016011046A2 (en)
CA (1) CA2928014A1 (en)
ES (1) ES2720728T3 (en)
HK (1) HK1225757A1 (en)
WO (1) WO2015071759A1 (en)
ZA (1) ZA201602703B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA45934A (en) 2016-08-10 2019-06-19 Centre Nat Rech Scient METHODS AND REAGENTS USED FOR DETECTION OF PIPERAQUIN RESISTANT PLASMODIUM FALCIPARUM MALARIA
CN109504791A (en) * 2018-12-29 2019-03-22 潮州市人民医院 For detecting the kit of plasmodium qinghaosu drug resistance correlation K13 gene mutation
CN109897901A (en) * 2019-02-27 2019-06-18 四川国际旅行卫生保健中心 Detect the specific primer group and its application of plasmodium falciparum k13 gene mutation site
CN109797207A (en) * 2019-02-27 2019-05-24 四川国际旅行卫生保健中心 A method of detection four resistance mutation sites of plasmodium falciparum k13 gene
CN112592395A (en) * 2020-12-11 2021-04-02 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) Construction, preparation and application of plasmodium falciparum RIFIN recombinant protein PfRIFIN-54

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
USRE32011E (en) 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (en) 1984-08-15 1986-03-07 Res Dev Corp Of Japan Chimera monoclonal antibody and its preparation
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
JPS63501765A (en) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド Antibody gene module assembly, antibodies produced thereby, and uses
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Method and kits for the amplification and detection of nucleic acid sequences
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
JP2650159B2 (en) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー Nucleic acid amplification method
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
ATE151110T1 (en) 1988-09-02 1997-04-15 Protein Eng Corp PRODUCTION AND SELECTION OF RECOMBINANT PROTEINS WITH DIFFERENT BINDING SITES
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
AU4829690A (en) 1988-12-16 1990-07-10 Siska Diagnostics, Inc. Self-sustained, sequence replication system
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
ES2139598T3 (en) 1990-07-10 2000-02-16 Medical Res Council PROCEDURES FOR THE PRODUCTION OF SPECIFIC UNION COUPLE MEMBERS.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
DK0546073T3 (en) 1990-08-29 1998-02-02 Genpharm Int Production and use of transgenic, non-human animals capable of forming heterologous antibodies
JP4146512B2 (en) 1991-03-01 2008-09-10 ダイアックス コープ. Small protein
DK1471142T3 (en) 1991-04-10 2009-03-09 Scripps Research Inst Heterodimeric receptor libraries using phagemids
DE4122599C2 (en) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid for screening antibodies
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US6582938B1 (en) 2001-05-11 2003-06-24 Affymetrix, Inc. Amplification of nucleic acids
EP2152899B1 (en) 2007-05-28 2012-11-14 Ehime University Primers for detecting plasmodium
CN100535125C (en) * 2007-06-28 2009-09-02 中国疾病预防控制中心寄生虫病预防控制所 Multiple PCR primer for expanding plasmodium falciparum drug resistance-related gene and method

Also Published As

Publication number Publication date
US10900093B2 (en) 2021-01-26
KR20160119753A (en) 2016-10-14
AU2014349828A1 (en) 2016-05-26
JP2020043873A (en) 2020-03-26
KR102283408B1 (en) 2021-07-29
JP6667445B2 (en) 2020-03-18
WO2015071759A1 (en) 2015-05-21
CN105940115A (en) 2016-09-14
HK1225757A1 (en) 2017-09-15
JP2016537030A (en) 2016-12-01
CN105940115B (en) 2021-07-06
US20210198755A1 (en) 2021-07-01
US11732312B2 (en) 2023-08-22
CA2928014A1 (en) 2015-05-21
AU2014349828B2 (en) 2021-01-28
EP3068903B1 (en) 2019-02-13
US20160289774A1 (en) 2016-10-06
WO2015071759A9 (en) 2016-06-23
BR112016011046A2 (en) 2019-01-29
ES2720728T3 (en) 2019-07-24
EP3068903A1 (en) 2016-09-21

Similar Documents

Publication Publication Date Title
IL245794A0 (en) Methods of detecting plasmodium infection
HK1206723A1 (en) Thienopyrimidines
HK1225757A1 (en) A molecular marker of plasmodium falciparum artemisinin resistance
SG11201401636YA (en) Multi-axis marker locator
GB2555067B (en) Marker deployment
EP2934378A4 (en) Catheter orienting markers
ZA201500656B (en) Marker vaccine
GB2504847B (en) A tubular connection
GB2506845B (en) Modified tubular
PL2989642T3 (en) Conductor marker
EP2829299A4 (en) Balloon catheter
EP2823864A4 (en) Training ladder
EP2818870A4 (en) Combined anticancer drug sensitivity-determining marker
HK1200538A1 (en) A tumor marker
EP2885638A4 (en) Molecular nets
HK1211888A1 (en) Tripterygium wilfordii extracts to overcome chemotherapy resistance
GB2508610B (en) Sports pitch marker
GB201322608D0 (en) Tubular body having decorative layer
EP2896692A4 (en) Cancer marker and application thereof
EP2805742A4 (en) Balloon catheter
HK1155034A2 (en) Marker pen
GB201308321D0 (en) Top marker
PL2885047T3 (en) Multi-layered tubing
FR2996774B1 (en) INFLATABLE BALLOON CATHETER
GB201314956D0 (en) Plaque marker for a garment hanger